Objective: In a systematic review, we compared ratio of new periprocedural radiographic brain ischemia (RBI) to the number of strokes and TIAs among patients undergoing carotid endarterectomy (CEA) and carotid artery stenting (CAS).
Carotid artery procedures such as carotid endarterectomy (CEA) or carotid artery stenting (CAS) have become a common surgical treatment approach for persons with internal carotid stenosis over the last 2 decades. Silent brain infarctions are clinically asymptomatic radiographic brain ischemia (RBI) that are found in brain imaging studies. Studies have largely reported on chronic silent brain infarction findings in epidemiologic studies and studies of stroke patients. 1, 2 After procedures that accompany the risk of stroke, acute silent brain infarctions have also been recognized on diffusion-weighted imaging (DWI) sequence of MRI. The frequency of periprocedural acute RBI on MRI is higher than clinically overt symptomatic infarcts such as strokes and TIAs. Reports vary in incidence of stroke, TIA, and RBI after invasive cardiovascular or cerebrovascular procedures. Although the clinical significance and implication of RBI is not clear, it has been suggested that RBI can increase the risk of cognitive impairment, dementia, future stroke, and mortality. [3] [4] [5] RBI can be detected after invasive procedures such as carotid interventions, cerebral angiography, cardiac catheterization, and cardiac surgeries. RBI or periprocedural ischemic events might serve as a potential surrogate marker for optimizing invasive procedures. 6 For MRI DWI to be a useful surrogate marker for procedural complications, a firm relationship between stroke complications and RBI should be made. In this study, we performed a systematic review and meta-analysis of symptomatic brain ischemia and RBI. We hypothesized that there is a consistent ratio of stroke and TIA to radiographic ischemia across the different carotid procedures. We secondarily aimed to compare RBI across different carotid procedure types. In other words, we hypothesized that the ratio of new RBI to new stroke or TIA syndromes after a carotid procedure would be constant regardless of the type of carotid procedure (CEA or CAS).
METHODS Search strategy. All procedures used in this meta-analysis were consistent with Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. 7 We searched MEDLINE (PubMed) and 5 other databases-EMBASE, Cochrane Library, Web of Science, clinicaltrials.gov, and Scopus-for subject headings and text related to brain ischemia in carotid artery interventions from inception of the databases and the final search was carried through September 2015. We used the following search terms and their combinations: MR imaging, silent infarct, asymptomatic infarct, cerebral infarct, new brain lesion, cerebral embolism, silent embolism, new brain infarct, coronary artery bypass graft (CABG), CABG, cardiac cath, cerebral angiogram, cerebral aneurysm coiling, carotid endarterectomy (CEA), CEA, transfermoral aortic valve implantation (TAVI), TAVI, carotid artery stenting (CAS), CAS. The search was refined to include only carotid procedures for this study. The search strategy for PubMed is available in appendix e-1.
Study eligibility: Inclusion and exclusion criteria. We included (1) all studies with CEA or CAS in a sample with varying degree of carotid stenosis; (2) if brain MRI was performed systematically preprocedure and postprocedure along with a postprocedure clinical neurologic examination; and (3) if new RBI and stroke incidence were reported after the procedures (CEA or CAS). We only included new MRI ischemia/lesions after the procedures for the analyses. We included studies in any language. We excluded case reports, editorials, commentaries, meta-analysis articles, review articles, animal studies, and articles with a pediatric population (age ,18 years). Study designs included both retrospective and prospective observational studies and randomized controlled trials (RCTs). We excluded studies that reported infarct incidence in a common study sample to avoid duplication and chose studies with larger and more inclusive sample size. The articles were discussed in detail among authors (S.M.C. and K.U.) in order to be excluded.
Data extraction and management. Ascertainment protocol of stroke and TIA after procedure varied across different studies. Systematic stroke ascertainment was defined if systematic neurologic examination was reported to have been performed after the procedures. The neurologic examination was done by health care providers including a neurologist, intervention/surgical team, nonintervention/surgical physician, NIH Stroke Scale-certified nurses, and unspecified providers, but mentioned the systematic neurologic examination was performed. Nonsystematic stroke ascertainment defined when there was no statement in the publication that participants were assessed more than routine clinical evaluation. The neurologic examination in the studies was performed along with the postprocedural MRI.
CAS studies were further divided into different subgroups based on the presence and the type of embolic protection device (proximal or distal protection). The subgroup with unspecified device included CAS cohorts with mixed protection device types, with unspecified number using protection devices, and unspecified type of device. When TIA and stroke are not clearly defined in the article, new ischemic stroke or TIA was defined as patients with new clinical symptoms or signs of focal cerebral or retinal dysfunction lasting less than or more than 24 hours without apparent cause other than of focal ischemic neurovascular origin (i.e., without imaging evidence of bleeding). Both TIAs and strokes are included in symptomatic brain ischemias, knowing that some TIAs may or may not have absent radiographic ischemias as the included studies do not specify this question. In our study, only new acute periprocedural RBI were collected by using MRI DWI excluding chronic RBI and such lesions may or may not be associated with focal neurologic deficits (stroke or TIA). CT brain imaging findings were not considered in our study.
Statistical analysis, assessment of heterogeneity, and risk of bias. Our main objective was to compare the rates of RBI to new stroke and TIA. A ratio between the 2 rates provides such a comparison in a single number. We calculated a symptomatic risk ratio (RR): RR 5 (new stroke and TIA)/RBI. RR is the weighted meta-analysis of ratio based on sample size in each study. We used random effects models with the inverse variance method. The RR is expressed with its 95% confidence interval (CI). Differences of RRs across subgroups were tested with a x 2 text; a p , 0.05 expressed differences across subgroups. Heterogeneity of RRs was tested with the Cochran x 2 test and the I 2 statistic. A p , 0.1 for the x 2 test was defined as indicating the presence of heterogeneity. I 2 quantified the degree of heterogeneity (high heterogeneity above 60%, low heterogeneity below 30%, intermediate heterogeneity between 30% and 60%).
The Newcastle-Ottawa Scale (NOS) was applied to evaluate risk of bias in 3 domains for cohort studies: the selection of the study groups, the comparability of the groups, and the ascertainment of either the exposure or outcome of interest for the studies. 8 The NOS uses 2 different tools for case-control and cohort studies and consists of 3 measures of quality: selection, comparability, and exposure/outcome assessment. The NOS assigns a maximum of 4 points for selection, 2 points for comparability, and 3 points for exposure or outcome. NOS scores of $7 were considered as having low risk of bias and NOS scores of 5-6 were considered as having moderate risk of bias. Any discrepancies were addressed by a joint re-evaluation of the original article. To assess the risk of bias of RCTs, we used The Cochrane Collaboration tool 9 ; each of the 8 items of this tool was judged as high risk, low risk, or unclear risk. Studies with high risk of bias in the items related to randomization or blinding were judged as having high risk of bias.
RevMan 5.3. software (Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014) was used for all analyses.
RESULTS
The literature search yielded 6,332 articles, and 59 studies (see appendix e-2 for references) involving 5,431 patients met the inclusion criteria (figure 1). Among the 59 studies, there were 22 cohorts in CEA, 34 cohorts in CAS with distal protection, 8 in CAS with proximal protection with or without flow reversal, 9 in CAS without protection, and 9 in CAS with unspecified devices. MRI DWI scans were performed in all 59 studies both before and after the procedures. Postprocedural MRIs were performed within 1-3 days. The majority of the studies (45 studies: 76%) utilized 1.5T MRI; 1 utilized 3.0T, 2 utilized 0.5T, and 11 included no MRI information. The reported mean time to postprocedural MRIs was a median of 2 days (interquartile range 1-3).
Overall, 1,594 participants (29.4%) had new ischemia on MRI, whereas only 231 (4.3%) manifested as clinical strokes or TIAs after the procedures.
Risk of bias assessment. Thirty-nine studies were case series. The NOS quality assessment was conducted on 14 cohort studies. For each meta-analysis, by using 3 domains of NOS (selection, comparability, and outcome), no evidence of high risk of bias was identified. The median NOS score was 8 (table e-1). The Cochrane Collaboration tool showed overall low risk or unclear risk of bias in 9 RCTs (table e-2).
Meta-analysis: Ratio of symptomatic (stroke and TIA) to radiographic ischemia. In meta-analysis, 30.7% (95% CI 26.6%-34.7%) of all carotid interventions (both CAS and CEA) had new RBI on MRI, while 3.2% (95% CI 2.6%-3.8%) had clinical strokes or TIAs (table 1) , with a ratio of stroke and TIA to RBI of 0.18 (95% CI 0.15-0.22). The reported RR differs from ratio of stroke and TIA percentage divided by infarct rate (i.e., raw ratio of 0.10 [3.1%/30.5%] vs Figure 1 Study flowchart for literature search and selection of studies weighed ratio of 0.18) because the RR is the weighted meta-analysis of ratio based on sample size in each study. The RR did not differ across 5 different types of carotid interventions (both CEA and CAS subgroups) without heterogeneity, showing a stable ratio of stroke and TIA to radiographic ischemia across the procedures (p 5 0.58, I 2 5 0%) (figures 2-4). Our analysis demonstrates that CEA (figure 2) had lower incidence of RBI compared to CAS (13.0% vs 37.4%; p , 0.0001). In CAS subgroups, the incidence of RBI was 23.0% in proximal protection (figure 2), 40.0% in distal protection (figure 3), 39.1% without protection, and 38.1% in unspecified devices ( figure 4) . When compared to each of the CAS subgroups, CEA had significantly lower frequencies of RBI (p , 0.0001). The heterogeneity of proportions across all studies was high (I 2 5 93%, 95% CI 93%-96%).
A higher periprocedural stroke and TIA rate in CAS compared to CEA was shown (4.1% vs 1.8%; p , 0.0001). In the CAS subgroup, the incidence of clinical strokes or TIAs was 2.3% in proximal protection, 4.0% in distal protection, 6.5% without protection, and 4.6% in unspecified devices. When Figure 2 Meta-analysis of risk ratios (RRs) in carotid endarterectomy (CEA) and carotid artery stenting (CAS) with proximal protection
Summary RR refers to these subgroups. Reference numbers refer to appendix e-2. CI 5 confidence interval.
compared to each type of CAS subgroup, CEA still had a significantly lower frequency of strokes/TIAs (p , 0.0001). Heterogeneity of proportions across all studies was low with I 2 of 29% (95% CI 0%-59%). When CEA was compared to the entire CAS group, there was no difference of RBI to stroke and TIA ratios between CEA and CAS (p 5 0.12) (figure e-1). This analysis showed a low heterogeneity of RRs within the CEA group and an intermediate heterogeneity of RRs within the CAS group.
Sensitivity analyses were performed to investigate the effect of the design or quality of study. There was no difference in RRs between RCTs and observational studies (p 5 0.12). There was low heterogeneity of RRs in RCTs; there is moderate heterogeneity of RRs in observational studies (figure e-2). The presence of reported systematic stroke ascertainment showed no statistical difference in RRs between nonsystematic (RR 0.19, 95% CI 0.15-0.24) and systematic postprocedural examination (RR 0.18, 95% CI 0.13-0.23), with p value of 0.72 (figure e-3).
DISCUSSION Our primary aim was to assess the ratio between new periprocedural stroke/TIA and new RBI on MRI DWI in order to see if there is a consistent ratio of symptomatic to radiographic ischemia across different carotid artery intervention studies. We found that there is a consistent ratio of 0.18 Figure 3 Meta-analysis of risk ratios (RRs) in carotid artery stenting (CAS) with distal protection
Reference numbers refer to appendix e-2. CI 5 confidence interval.
across the carotid interventions. In other words, approximately 1 out of 5 persons with periprocedural radiographic ischemia had new stroke or TIA symptoms. This ratio did not differ among different types of carotid procedures or different types of study design. This number can be used to translate radiographic ischemia to estimate clinical significant events and vice versa when MRI is used as a surrogate marker of procedural safety. While our analysis is a metaanalysis of ischemia in carotid artery interventions that assessed the ratio between symptomatic ischemia and RBI across carotid procedures, our finding is in keeping with frequency of symptomatic and silent brain infarctions observed in epidemiologic studies.
In longitudinal cohort studies of elderly persons in the community with repeated MRI, only 1 in 6-8 persons with new RBI between the 2 MRI scans had experienced stroke symptoms. 10, 11 As one of the meta-analysis studies to directly compare RBI in CEA and CAS, our study brings up several additional interesting discussion points. Our systematic review demonstrates that approximately a third of persons undergoing CAS harbor MRI-detectable ischemia, and this is approximately triple the rate of CEA. These findings are consistent with prior small RCTs and metaanalyses.
12-14 A substudy of the International Carotid Stenting Study, a randomized comparison of symptomatic CAS and CEA, showed that CAS carries a higher risk of periprocedural cerebral ischemia in DWI compared to CEA. 12 The rate of symptomatic ischemia (stroke or TIA) parallels radiographic ischemia, with a higher stroke and TIA rate in CAS (4.1%) compared to CEA (1.8%), which is congruent with pooled analysis and systematic reviews of RCTs comparing CEA vs CAS. [15] [16] [17] [18] [19] However, this comparison should be interpreted carefully since the meta-analysis is derived from a heterogeneous sample of mostly nonrandomized cohorts.
The ischemic events are thought to be due to embolic debris during carotid interventions. Various embolic protection devices have been proposed and Figure 4 Meta-analysis of risk ratios (RRs) in carotid artery stenting (CAS) without protection, CAS with protection of mixed devices, and overall RR across 5 subgroups (from figures 2-4)
utilized. Evidence for this is limited with few RCTs with small samples and observational studies. 20, 21 In our analysis, CAS with embolic protection devices seems to offer a better protection in ischemic lesions compared to CAS without protection, consistent with prior smaller analysis. 22 We found no association of design of study with the ratio of symptomatic to radiographic ischemia. RCTs or reporting of systematic neurologic examination were not associated with higher ratio of symptoms being found among those with radiographic ischemia. Rothwell et al. 23 reported in a systematic review of CEA that neurologist assessment after surgery and other methodologic differences accounted for variability risk of CEA. If trial design influenced stroke ascertainment and variability were great in the RR, RBI would represent a more objective, lessbiased evidence of procedural complications. Our finding does not support this hypothesis. The importance of MRI as an endpoint after a carotid procedure may be statistically advantageous: the higher rate of RBI would be associated with larger power and require smaller sample size compared to stroke and TIAs in comparing different methodologies in periprocedural ischemia.
A large number of studies included for the analysis is the strength of this study. However, our study has several limitations. Across the large number of studies, clearly the procedural details differ. But ratio of symptomatic to radiographic ischemia was hypothesized to be relatively constant despite variations in ischemia rates. Indeed, there appears to be a stable ratio. When the comparisons are ischemia rates among procedures, the procedural details may matter and we are unable to account for operator differences and changes in procedural methodology that may occur over time, except for the CAS protection methods. MRI methodology differs across studies, including magnetic field strength 24 and postprocedural imaging time interval that might affect sensitivity of DWI. DWI lesion reversal can occur especially if the lesions are small. 25 We did not account for periprocedural ischemia that occurred days to weeks after the procedure 26 as the most studies did not collect such information. We have no information about the relationship between radiographic ischemia numbers, size, and location in each patient to their symptomatic status. The constant ratio of symptomatic to radiographic ischemia across procedures suggests that while there are individual differences why an infarct is symptomatic, the type of procedure do not result in different ischemia characteristics. The reporting of operation on symptomatic or asymptomatic carotid artery, the degree of carotid stenosis, or contralateral carotid artery disease is incomplete and varies across studies. The majority of studies included asymptomatic carotid disease and the inclusion criteria for the degree of carotid stenosis varies from greater than 31% to greater than 90%. In addition, differentiation between symptomatic and asymptomatic patients is lacking in most of the studies. Although we looked to see if there was variability in stroke ascertainment, this bias is difficult to measure. Significant heterogeneity was found in few subgroup analyses, which was expected due to the differences in type of the procedures that were performed. The significant variability in methodology and reporting in the carotid literature indicates that there should be better academic reporting standards and knowledge on evidence-based medicine for physicians who perform carotid procedures.
One in five persons with periprocedural RBI during CEA and CAS were associated with new strokes and TIAs and the ratio of stroke/TIAs to RBI was similar across the different carotid procedures. The stable ratio of symptomatic brain ischemia to RBI suggests that radiographic infarcts could serve as a surrogate measure of periprocedural risk for cerebral ischemia. 
AUTHOR CONTRIBUTIONS

STUDY FUNDING
No targeted funding reported.
DISCLOSURE
